| ISSUE |
EDITORIAL |
| January 2012 |
(1) Bowman's β-Catenin
(2) Polarity and Renal Cystogenesis
(3) Pyridoxamine, Advanced Glycation Inhibition, and Diabetic Nephropathy
(4)Vasculitis Is an Antiangiogenic State
(5)Sodium Intake, ACE Inhibition, and Progression to ESRD
(7)Chronotherapy in Hypertension: A Pill at Night Makes Things Right?
|
| February 2012 |
(1) A Look at Transactivation of the EGF Receptor by Angiotensin II
(2) Managing Microvascular Complications of Diabetes with MicroRNAs
(3) Sphingosine Lipids in the Resolution of Renal Ischemia and Reperfusion Injury
(4)The Crossroad of RAAS Modulation, Inflammation, and Oxidative Stress in Dialysis Patients: Light at the End of the Tunnel?
(5)ESAs in Transplant Anemia: One Size Does Not “Fit All”
|
| March 2012 |
(1) Life Without Nephrin: It's for the Birds
(2) Induction of IgA Deposits and Glomerulonephritis by IgA Rheumatoid Factor
(3) Illuminating the Glomerular Filtration Barrier, Two Photons at a Time
(4)Do We Now Have a Prognostic Biomarker for Progressive Diabetic Nephropathy?
(5)Anti–LAMP-2 Autoantibodies in ANCA-Associated Pauci-Immune Glomerulonephritis
|
| April 2012 |
(1) Is the Albumin Retrieval Hypothesis a Paradigm Shift for Nephrology?
(2) The Eternal (Nocturnal) Quest for Better Dialysis Outcomes
(3) Intensive Hemodialysis: Back to the Beginning?
(4) Improvement in Kidney Function: A Real Occurrence
|
| May 2012 |
(1) microRNA-Induced IgA Nephropathy
(2) Activated Pericytes and the Inhibition of Renal Vascular Stability: Obstacles for Kidney Repair
(3) The Impact of Renal Function on Outcomes of Bariatric Surgery
(4) New Observational Data Demonstrate that Mortality Is Lower in Patients Receiving More Frequent Dialysis
|
| June 2012 |
(1) Yes, AKI Truly Leads to CKD
(2) A Photo Shoot of Proteinuria: Zebrafish Models of Inducible Podocyte Damage
(3) Human AKI and Heme Oxygenase-1
(4) On-Line Hemodiafiltration: Not a Self-Fulfilling Prophecy
(5)Rituximab in Steroid-Resistant Nephrotic Syndrome in Children: A (False) Glimmer of Hope?
|
| July 2012 |
(1) Knocking Out Podocyte Rho GTPases: And the Winner Is…
(2) The Increasing Complexity of the Intratubular Renin-Angiotensin System
(3) Renal Nerves and CKD: Is Renal Denervation the Answer?
|
| August 2012 |
(1) Glomerular Homeostasis Requires a Match between Podocyte Mass and Metabolic Load
(2) Dying Cells and Extracellular Histones in AKI: Beyond a NET Effect?
(3) Phosphate Binders in CKD: Bad News or Good News?
(4) Rituximab in Membranous Nephropathy: Is It a First-Line Treatment?
|
| September 2012 |
(1)Angiotensin Converting Enzyme Inhibitor–Modulated MicroRNAs Targeting Renal Fibrosis
(2)Aquaporin 2: Not Just for Moving Water
(3)Lifetime Risk of ESRD: A Meaningful Concept?
(4)Randomized Trial of Pre-Emptive or Prophylactic Valganciclovir Therapy for Prevention of Cytomegalovirus Infection in Renal Transplantation
|
| October 2012 |
(1)Partial Answers from Partial Klotho Deficiency
(2)New Treatments for CKD—New Insights into Pathogenesis
(3)Connecting the Segments
(4)Urinary Albumin: How Low Is Normal?
(5)How Benign Is IgA Nephropathy with Minimal Proteinuria?
|
| November 2012 |
(1)Uromodulin, Inflammasomes, and Pyroptosis
(2)Growing New Kidneys from Embryonic Cell Suspensions: Fantasy or Reality?
(3)Parathyroid Hormone–Independent Role for the Calcium-Sensing Receptor in the Control of Urinary Calcium Excretion
|
| December 2012 |
(1)Small RNAs Have a Big Effect on Polycystic Kidney Disease
(2)Monoclonal Anti-PLA2R and Recurrent Membranous Nephropathy: Another Piece of the Puzzle
(3)Mast Cells: Subordinates or Masterminds in Autoimmunity?
(4)Kidney Disease Progression and Screening Cost-Effectiveness among African Americans
|
